Autopsy report · NCT04726085

Ibuprofen Versus Indomethacin Following Emergent Cerclage Placement

“Investigative team moved institutions”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 9 months before it stopped.
• 11 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Woman's

Sponsor type

University, hospital or other

Conditions

Preterm Labor

Interventions

Indomethacin 150mg; Ibuprofen 2400mg

Participants

11

Sites

1

Countries

United States

Trials that died the same way

• Dupilumab Phase 4 Study
  “Investigator moved from institution.” (76% match in meaning)
• A Study of Oral L-citrulline in Sickle Cell Disease
  “Principal Investigator moved to another institution” (74% match in meaning)
• Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
  “Investigator Left Institution” (74% match in meaning)
• BFR Therapy After ACL Reconstruction
  “Investigator separated from institution” (73% match in meaning)
• A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease
  “Principal Investigator has moved to another institution” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.